[
  {
    "section": "section:1",
    "title": "Abstract"
  },
  {
    "section": "section:1",
    "title": "INTRODUCTION"
  },
  {
    "section": "section:1",
    "title": "RESULTS"
  },
  {
    "section": "section:2",
    "title": "Demographics"
  },
  {
    "section": "section:2",
    "title": "Safety Profile"
  },
  {
    "section": "section:2",
    "title": "Pharmacokinetics"
  },
  {
    "section": "section:2",
    "title": "Antitumor Activity"
  },
  {
    "section": "section:2",
    "title": "Phase 2-Eligible Population"
  },
  {
    "section": "section:2",
    "title": "Intracranial Activity"
  },
  {
    "section": "section:1",
    "title": "DISCUSSION"
  },
  {
    "section": "section:1",
    "title": "METHODS"
  },
  {
    "section": "section:2",
    "title": "Study Design"
  },
  {
    "section": "section:2",
    "title": "Study Population"
  },
  {
    "section": "section:2",
    "title": "Safety Assessments"
  },
  {
    "section": "section:2",
    "title": "Pharmacokinetics"
  },
  {
    "section": "section:2",
    "title": "Pharmacodynamics"
  },
  {
    "section": "section:2",
    "title": "Tumor Assessments"
  },
  {
    "section": "section:2",
    "title": "Statistical Analysis"
  },
  {
    "section": "section:1",
    "title": "References"
  },
  {
    "section": "section:1",
    "title": "Figure 1"
  },
  {
    "section": "section:1",
    "title": "Figure 2"
  },
  {
    "section": "section:1",
    "title": "Figure 3"
  },
  {
    "section": "section:1",
    "title": "Figure 4"
  },
  {
    "section": "section:1",
    "title": "Table 1"
  },
  {
    "section": "section:1",
    "title": "Table 2"
  },
  {
    "section": "section:1",
    "title": "Table 3"
  }
]